Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126266051 | 12626605 | 1 | I | 200509 | 20160802 | 20160805 | 20160805 | PER | US-BAYER-2016-151802 | BAYER | 46.00 | YR | A | F | Y | 0.00000 | 20160805 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126266051 | 12626605 | 1 | PS | YASMIN | DROSPIRENONEETHINYL ESTRADIOL | 1 | 21098 | FILM-COATED TABLET | |||||||||||
| 126266051 | 12626605 | 2 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | 0 | ||||||||||||
| 126266051 | 12626605 | 3 | C | DALTEPARIN | DALTEPARIN | 1 | 0 | ||||||||||||
| 126266051 | 12626605 | 4 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 126266051 | 12626605 | 5 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 126266051 | 12626605 | 6 | C | ATIVAN | LORAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126266051 | 12626605 | 5 | Anxiety |
| 126266051 | 12626605 | 6 | Sleep disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126266051 | 12626605 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126266051 | 12626605 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |